DK0873136T3 - Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme - Google Patents

Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme

Info

Publication number: DK0873136T3
Authority: DK; Denmark
Prior art keywords: pct; factor; specific immune; date; methods
Prior art date: 1995-10-27

Application number

DK96939501T

Other languages

Danish (da)

English (en)

Inventor

Geoffrey M Thiele

Thomas L Mcdonald

Dean J Tuma

Lynell W Klassen

Michael F Sorrell

Original Assignee

Univ Nebraska

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1995-10-27

Filing date

1996-10-25

Publication date

2005-01-24

1996-10-25 Application filed by Univ Nebraska filed Critical Univ Nebraska

2005-01-24 Application granted granted Critical

2005-01-24 Publication of DK0873136T3 publication Critical patent/DK0873136T3/da

Links

230000002708 enhancing effect Effects 0.000 title 1
GHUJOXJDUAROKJ-UHFFFAOYSA-N 4-methyl-1,4-dihydropyridine-3,5-dicarbaldehyde Chemical compound CC1C(C=O)=CNC=C1C=O GHUJOXJDUAROKJ-UHFFFAOYSA-N 0.000 abstract 1
238000002835 absorbance Methods 0.000 abstract 1
239000000427 antigen Substances 0.000 abstract 1
102000036639 antigens Human genes 0.000 abstract 1
108091007433 antigens Proteins 0.000 abstract 1
150000001720 carbohydrates Chemical class 0.000 abstract 1
235000014633 carbohydrates Nutrition 0.000 abstract 1
230000005284 excitation Effects 0.000 abstract 1
230000002163 immunogen Effects 0.000 abstract 1
150000002632 lipids Chemical class 0.000 abstract 1
102000004169 proteins and genes Human genes 0.000 abstract 1
108090000623 proteins and genes Proteins 0.000 abstract 1

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D211/00—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings
- C07D211/04—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom
- C07D211/80—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members
- C07D211/82—Heterocyclic compounds containing hydrogenated pyridine rings, not condensed with other rings with only hydrogen or carbon atoms directly attached to the ring nitrogen atom having two double bonds between ring members or between ring members and non-ring members with only hydrogen atoms, hydrocarbon or substituted hydrocarbon radicals, directly attached to ring carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K39/385—Haptens or antigens, bound to carriers
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P37/00—Drugs for immunological or allergic disorders
- A61P37/02—Immunomodulators
- A61P37/04—Immunostimulants
- G—PHYSICS
- G01—MEASURING; TESTING
- G01N—INVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
- G01N33/00—Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
- G01N33/48—Biological material, e.g. blood, urine; Haemocytometers
- G01N33/50—Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
- G01N33/53—Immunoassay; Biospecific binding assay; Materials therefor
- G01N33/531—Production of immunochemical test materials
- G01N33/532—Production of labelled immunochemicals
- G01N33/533—Production of labelled immunochemicals with fluorescent label
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/555—Medicinal preparations containing antigens or antibodies characterised by a specific combination antigen/adjuvant
- A61K2039/55511—Organic adjuvants
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K39/00—Medicinal preparations containing antigens or antibodies
- A61K2039/60—Medicinal preparations containing antigens or antibodies characteristics by the carrier linked to the antigen
- A61K2039/6012—Haptens, e.g. di- or trinitrophenyl (DNP, TNP)

Landscapes

Health & Medical Sciences (AREA)
Immunology (AREA)
Life Sciences & Earth Sciences (AREA)
Chemical & Material Sciences (AREA)
Engineering & Computer Science (AREA)
Organic Chemistry (AREA)
General Health & Medical Sciences (AREA)
Medicinal Chemistry (AREA)
Microbiology (AREA)
Molecular Biology (AREA)
Urology & Nephrology (AREA)
Hematology (AREA)
Public Health (AREA)
Veterinary Medicine (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Biomedical Technology (AREA)
General Physics & Mathematics (AREA)
General Chemical & Material Sciences (AREA)
Pathology (AREA)
Mycology (AREA)
Analytical Chemistry (AREA)
Epidemiology (AREA)
Physics & Mathematics (AREA)
Food Science & Technology (AREA)
Cell Biology (AREA)
Bioinformatics & Cheminformatics (AREA)
Chemical Kinetics & Catalysis (AREA)
Biochemistry (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Biotechnology (AREA)
Peptides Or Proteins (AREA)
Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
Medicines Containing Material From Animals Or Micro-Organisms (AREA)
Saccharide Compounds (AREA)
Medicines Containing Antibodies Or Antigens For Use As Internal Diagnostic Agents (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Compounds Of Unknown Constitution (AREA)

DK96939501T 1995-10-27 1996-10-25 Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme DK0873136T3 (da)

Applications Claiming Priority (2)

Application Number	Priority Date	Filing Date	Title
US595995P	1995-10-27	1995-10-27
PCT/US1996/017240 WO1997015324A1 (en)	1995-10-27	1996-10-25	High fluorescence specific immune enhancing factor and methods of use for same

Publications (1)

Publication Number	Publication Date
DK0873136T3 true DK0873136T3 (da)	2005-01-24

Family

ID=21718568

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
DK96939501T DK0873136T3 (da)	1995-10-27	1996-10-25	Specifik immunforögende faktor med höj fluorescens og fremgangsmåder til anvendelse af samme

Country Status (9)

Country	Link
US (1)	US6120777A (de)
EP (1)	EP0873136B1 (de)
JP (1)	JP2000505056A (de)
AT (1)	ATE279207T1 (de)
AU (1)	AU726344B2 (de)
CA (1)	CA2235599A1 (de)
DE (1)	DE69633635T2 (de)
DK (1)	DK0873136T3 (de)
WO (1)	WO1997015324A1 (de)

Families Citing this family (2)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
JP2001518556A (ja) *	1997-10-03	2001-10-16	ガレニカファーマシューティカルズ，インコーポレイテッド	イミン形成ポリサッカライド、その調製、ならびにアジュバントおよび免疫刺激剤としてのその使用
GB0326439D0 (en) *	2003-11-13	2003-12-17	Imp College Innovations Ltd	Methods

1996
- 1996-10-25 US US08/849,024 patent/US6120777A/en not_active Expired - Fee Related
- 1996-10-25 AT AT96939501T patent/ATE279207T1/de not_active IP Right Cessation
- 1996-10-25 JP JP9516852A patent/JP2000505056A/ja active Pending
- 1996-10-25 DE DE69633635T patent/DE69633635T2/de not_active Expired - Fee Related
- 1996-10-25 DK DK96939501T patent/DK0873136T3/da active
- 1996-10-25 EP EP96939501A patent/EP0873136B1/de not_active Expired - Lifetime
- 1996-10-25 AU AU76654/96A patent/AU726344B2/en not_active Ceased
- 1996-10-25 CA CA002235599A patent/CA2235599A1/en not_active Abandoned
- 1996-10-25 WO PCT/US1996/017240 patent/WO1997015324A1/en not_active Ceased

Also Published As

Publication number	Publication date
AU7665496A (en)	1997-05-15
DE69633635T2 (de)	2006-03-09
EP0873136A2 (de)	1998-10-28
WO1997015324A1 (en)	1997-05-01
JP2000505056A (ja)	2000-04-25
CA2235599A1 (en)	1997-05-01
DE69633635D1 (de)	2004-11-18
ATE279207T1 (de)	2004-10-15
US6120777A (en)	2000-09-19
EP0873136B1 (de)	2004-10-13
EP0873136A4 (de)	2001-11-07
AU726344B2 (en)	2000-11-02

Similar Documents

Publication	Publication Date	Title
IL134392A0 (en)	2001-04-30	Vaccine against hpv
BR9814487A (pt)	2000-10-10	"vacina"
DE69637642D1 (de)	2008-09-25	Und kombinierte zusammensetzungen und deren verwendung
TR199801722T2 (xx)	1998-12-21	Peptit imm�nojenler.
ATE231917T1 (de)	2003-02-15	Immunresponse gegen hpv antigene erregt von zusammensetzungen die ein hpv antigen und ein stressprotein enthalten oder einen expressionsvektor fähig zur expression dieser proteine
ATE454163T1 (de)	2010-01-15	Bakterielle impfstoffe, enthaltend auxotrophe attenuierte listerienstämme, welche heterologe antigene exprimieren
DK0817846T3 (da)	2005-11-07	Intracellulært domæne af HER-2/neu proteinet til forebyggelse eller behandling af maligniteter
WO2003045128A3 (en)	2006-04-06	SYNTHETIC IMMUNOGENIC BUT NON-DEPOSIT-FORMING POLYPEPTIDES AND PEPTIDES HOMOLOGOUS TO AMYLOID β, PRION PROTEIN, AMYLIN, α-SYNUCLEIN, OR POLYGLUTAMINE REPEATS FOR INDUCTION OF AN IMMUNE RESPONSE THERETO
ATE125157T1 (de)	1995-08-15	Methoden und zusammensetzungen zur impfung gegen hiv.
NO20013701L (no)	2001-09-28	HER-2/neu-fusjonsproteiner
NO924780L (no)	1993-06-14	Ekspresjon av spesifikke immunogener ved bruk av virusantigener
DE69431404D1 (de)	2002-10-24	Verfahren zur mikroverkapselung von antigenen und verwendung der zusammensetzungen als impfstoffe
DE69429723D1 (de)	2002-03-14	Stressproteine und ihre verwendung
JPS56131523A (en)	1981-10-15	Vaccine composite containing idiosyncratic antigen and vaccine containing idiosyncratic antigen
DK0555276T3 (da)	1995-09-18	Immunogene komplekser, især iscomer
BR9906927A (pt)	2001-11-20	Proteìnas de neisseria meningitidis
MX9801159A (es)	1998-05-31	Metodos de reduccion o para mantener los niveles reducidos de lipidos en la sangre usando composiciones de proteina ob.
WO2000056901A3 (en)	2001-05-31	Linear and circular expression elements
AU691995B2 (en)	1998-05-28	Interference-suppressing reagent specific to certain classes of antibodies
AU2316892A (en)	1993-01-25	Multiple emulsions and methods of preparation
DE69727595D1 (de)	2004-03-18	Verfahren zur herstellung eines extraktes des plättchenwachstumsfaktors für zubereitungen zur wundheilung
NO20024571D0 (no)	2002-09-24	Immunoterapeutiske fremgangsmåter og blandinger
EP0602046A4 (de)	1995-07-19	Detektion des immunschwäche-virus aus säugetieren.
ES2196150T3 (es)	2003-12-16	Induccion de tolerancia inmunologica por el uso de anticuerpos anti-cd4 que no inducen deplecion.
DE69229269D1 (de)	1999-07-01	Peptidfragmente des menschlichen cytochrome p450 iid6, antikörper dagegen und ihre verwendungen in diagnostik